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techniques have long been consid-
ered the "gold standard" for the detection of
Ca/amydia tracaomatis. The major advantage of cell-
culture isolation is the specificity, which ap-
proaches 100%; however, even in experienced
laboratories, its sensitivity is only 70-80%. 1-3 Its
primary use has been in detecting symptomatic car-
riers in low-prevalence populations. Nonculture
objective methods, such as enzyme immunoassay,
DNA probe, polymerase chain reaction (PCR), and
ligase chain reaction (LCR), have been used
primarily in symptomatic or high-risk, high-
prevalence asymptomatic populations (Table 1).
NEW GOLD STANDARD?
Lee et al. have proposed that the gold standard for
C. trachomatis be redefined as all culture-positive as
well as culture-negative LCR-positive individuals.4
In a study of 1,935 women in which the first-voided
urine specimens were compared to endocervical
swabs using an LCR-based assay versus cell tissue
culture techniques, the LCR assay showed a de-
tection rate for infected women almost 30% greater
than that of the endocervical swab cultures. The
overall resolved sensitivity of LCR on first-voided
specimen was 93.8%, compared with a sensitivity
of only 65.0% for cultures of endocervical swab
samples. The problem with urine tests is that prior
culture studies have shown that 5-30% of infected
women have only urethral colonization.3 Only 50-
60% of infected women have both endocervical
and urethral infection.
In a subsequent study, Schachter et al. com-
pared first-catch urine LCR test with cell culture
isolations from the cervix and urethra. Compared
with the cervical cultures, LCR was 88.2% sensi-
tive and 100% specific. Adding urethral culture in-
creased the tissue culture sensitivity from 67.1% to
74% and reduced LCR sensitivity to 85.9%.s The
observed increase in sensitivity does not appear to
be associated with a reciprocal loss of specificity.
Tests of copies of genomic DNA of commonly iso-
lated bacteria, protozoans, etc., in the urogenital
tract were negative in all cases studied,s-7
Hadgu has focused a problem which will delay a
final decision as to the new gold standard,s The
discrepant analysis, which is used to provide esti-
mates of sensitivity and specificity in the presence
of an imperfect gold standard that has been applied
to estimate the sensitivity and specificity of DNA-
amplification tests for C. trachomatis, is usually bi-
ased.
PCR VERSUS LCR IN WOMEN
BEING TESTED
Polymerase chain reaction tests are both sensitive
and specific in detecting chlamydial infections in
men; PCR may be slightly more sensitive than
LCR assay in diagnosing C. trachomatis infection in
men in a test of first-void urine. The problem with
PCR is that endocervical specimens contain inhibi-
tors that appear to reduce the sensitivity.
9-1 This
susceptibility of PCR tests to inhibitive factors in
cervical specimens can be significantly reduced by
pretreatment procedures, including heating treat-
ment or the use of 2SP transport medium. A 10-
fold dilution of the clinical specimen followed by
heating treatment further prevents inhibition of
the PCR tests.
The problem of inhibitory factors in cervical
samples and the inability to obtain screening speci-
mens without using a speculum tend to sustain the
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TABLE I. Non-culture tests for the detection of Chlamydia trachomatis
Test Principle Use
Direct fluorescent antibody
Enzyme immunoassay
Nucleic acid hybridization
(DNA probe)
Amplification procedures
(-polymerase chain reaction,
-ligase chain reaction)
Utilizes antibodies directed against either the
genus-specific lipopolysaccharide or the
species-specific, major outer-membrane proteins.
Detects chlamydia lipopolysaccharide with primarily
polyclonal antibody that has been linked with an
enzyme.
Utilizes an acridinium ester-labeled single-stranded
DNA probe that is complimentary to the RRNA of
Chlamydia trachomatis.
Amplifies a target DNA sequence via the designated
enzyme. One molecule of target DNA can
potentially be amplified one billion times.
Advocated for small-volume testing
where quality of the specimen is
an issue.
Best used in high-prevalence
populations (owing to low
sensitivity).
Highest sensitivity
concept that LCR will become the methodology of
choice for the discipline of obstetrics and gynecol-
ogy. A new gold standard in terms of sensitivity and
specificity appears in evolution and, when estab-
lished, may be challenged by even new technolo-
gies. Obstetricians and gynecologists need to con-
ceptually prepare for change. Beyond the choice of
a new gold standard will be the issue of what, urine
alone or endocervical and urine specimens com-
bined, will be required for the gold standard test in
women.
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